As one of the life science and pharmaceutical industry's most international and most often held partnering events for business deals, euroPLX will be held for the 51st time. At euroPLX 51 Limassol you will only meet pharma and biopharma executives who are in charge of their companies' business development. euroPLX stands for for continuous, productive pharma partnering since 1995. Partnering scope: Registrants determine the "Dynamic Partnering Focus" of this event, displayed on www.europlx.com. It evolves and changes over time within a range from patented to generic (incl. biosimilars), from prescription to OTC drugs, companion diagnostics, nutraceuticals, and medical devices: development, licensing, marketing, promotion, and distribution.